Bain Capital Set to Acquire Mitsubishi Tanabe Pharma for $3.3 Billion
4 months ago
In a significant move within the pharmaceutical sector, Bain Capital has announced its intent to acquire Mitsubishi Tanabe Pharma Corporation in a deal valued at $3.3 billion. This acquisition marks a pivotal moment for Bain, as it expands its footprint in the biopharmaceutical industry, acquiring one of Japan's notable pharmaceutical firms.
Continue reading
GSK Set to Acquire US Cancer Biotech IDRx in Landmark $1.15 Billion Deal
5 months ago
In a significant move within the pharmaceutical landscape, GlaxoSmithKline (GSK) has announced its intention to acquire U.S.-based cancer biotechnology firm IDRx for a staggering amount that could reach up to $1.15 billion. This bold acquisition underscores GSK's commitment to expanding its oncology portfolio as it aims to bolster its presence in the competitive cancer treatment market.
Continue reading